CLA-2-29:S:N:N7:238 887496
Mr. James A. Arcure
Astra USA, Inc.
P.O. Box 4500
Westborough, MA 01581-4500
RE: The tariff classification of Budesonide (CAS# 51333-22-3), an anti-
inflammatory drug, imported in bulk form, from Sweden
Dear Mr. Arcure:
In your letter dated June 16, 1993, you requested a tariff classification
ruling.
Budesonide [[product is a mixture of [11-beta, 16-alpha (R), (S)]
isomers; chemical name: 16,17-butylidenebis(oxy)-11,21-dihydroxy-[11-beta,16-
alpha]-pregna-1,4-diene-3,20-dione]] is a glucocorticoid hormone, which is
used as an anti-inflammatory drug. The product will be imported in bulk form,
as a powder.
The applicable subheading for Budesonide, imported in bulk form, will be
2937.29.0050, HTS, which provides for hormones, natural or reproduced by
synthesis; derivatives thereof, used primarily as hormones; other steroids
used primarily as hormones: adrenal cortical hormones and their derivatives:
other: other. The rate of duty will be 6 percent ad valorem.
This merchandise may be subject to the regulations of the Food and Drug
Administration. You may contact them at 5600 Fishers Lane, Rockville, MD
20857, telephone number (202) 857-8400.
With respect to your request for a tariff classification ruling on
inhalers containing Budesonide as the active ingredient, please be advised
that your request is being forwarded to U.S. Customs Service Headquarters,
Office of Regulations and Rulings, Commercial Rulings Division, Franklin
Court, 1301 Constitution Ave., NW, Washington, DC 20029, for their review. A
ruling will be issued to you from that office.
This ruling is being issued under the provisions of Section 177 of the
Customs Regulations (19 C.F.R. 177).
A copy of this ruling letter should be attached to the entry documents
filed at the time this merchandise is imported. If the documents have been
filed without a copy, this ruling should be brought to the attention of the
Customs officer handling the transaction.
Sincerely,
Jean F. Maguire
Area Director
New York Seaport